Blog | DeepQure

top of page

For Patients
HyperQure
About HyperQure
Technology Pipeline
About HyperQure
Technology Pipeline
Resources
Blog
Media Coverage
Blog
Media Coverage
About
About DeepQure
Our Team
Our Advisors
Investor Relations
About DeepQure
Our Team
Our Advisors
Investor Relations

DeepQure's HyperQure system

DeepQure's HyperQure system

Inside DeepQure with Co-Founders Mr Chan-Ho Park and Dr Chang Wook Jeong

HyperQure is currently the only solution under development that's designed to perform renal denervation using an extravascular approach

HyperQure is currently the only solution under development that's designed to perform renal denervation using an extravascular approach

The Differences Between Catheter-based And Extravascular RDN

DeepQure's HyperQure renal denervation system

DeepQure's HyperQure renal denervation system

Renal Denervation: A Market in Search of the Right Solution

RDN clinical pathway for hypertensive patients

RDN clinical pathway for hypertensive patients

Renal Denervation’s Clinical Pathway: Who’s Involved?

Renal denervation using DeepQure's HyperQure system

Renal denervation using DeepQure's HyperQure system

Hypertension Treatment: Drugs vs Renal Denervation

understanding hypertension

understanding hypertension

Renal Denervation 101: Understanding Hypertension and RDN

© 2025 DeepQure Inc. All rights reserved.

This site and its contents are the property of DeepQure Inc and may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of DeepQure Inc.

HyperQure

About HyperQure

Resources

About

Investor Relations

For Patients
HyperQure
- About HyperQure
- Technology Pipeline
Resources
- Blog
- Media Coverage
About

bottom of page